Alignment Healthcare, Inc.

Alignment Healthcare, Inc.(ALHC)股票分析

$8.230

-0.069 (-0.84%)收盤時

Loading chart…
最高
8.528
開盤
8.385
成交量加權均價
8.28
成交量
6.76M
市值
1.50B
最低
8.085
成交金額
55.98M
企業價值/稅息折舊攤銷前利潤(TTM)
5.56

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

AI 分析 of Alignment Healthcare, Inc. (ALHC)

賣出

Alignment Healthcare Inc is not a good buy right now due to significant negative catalysts affecting its stock. The current price is $7.545, and the recent downgrade of its Medicare star rating from 4 stars to 3.5 stars has resulted in a potential revenue loss of hundreds of millions, which is a critical risk. Additionally, the stock has seen a year-to-date decline of 62.69%, indicating severe market sentiment against it.

估值指標

Alignment Healthcare, Inc.(ALHC)目前預期本益比為 204.08,5 年平均預期本益比為 -31.73。

預期本益比

合理
5 年均值 P/E
-31.73
目前P/E
204.08
高估
395.02
低估
-458.47

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-65.55
目前EV/EBITDA
5.56
高估
244.03
低估
-375.14

預期股價營收比

低估
5 年均值 P/S
0.90
目前P/S
0.26
高估
1.43
低估
0.37

Alphio AI 對 ALHC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ALHC

$27.62

情境價格

基

基準

基準 · 50%ALHC

$23.77

情境價格

悲

悲觀

悲觀 · 25%ALHC

$19.40

情境價格

持有 ALHC 的大戶

O

Osterweis Capital Management, Inc.

+ 持有ALHC

+2.70%

3個月報酬率

D

Danske Bank A/S

+ 持有ALHC

+2.29%

3個月報酬率

B

Burkehill Global Management, LP

+ 持有ALHC

-1.09%

3個月報酬率

I

Integral Health Asset Management, LLC

+ 持有ALHC

-8.58%

3個月報酬率

Q

Qatar Holding LLC

+ 持有ALHC

-9.36%

3個月報酬率

事件時間軸

2026-10-09 (ET)

16:30:00

Trump Says U.S. Will Not Strike Iran, Oil Pulls Back

12:00:00

Tech Stock Rebound Boosts Major Averages

09:00:00

U.S. Stock Futures Rise as Oil Prices Ease, Boosting Market Recovery

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

17:00:00

Alignment Healthcare Shares Down 20% to $6.99

資訊

ALHC 常見問題 —— 由 Alphio AI 解答

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Alignment Healthcare Inc is not a good buy right now due to significant negative catalysts affecting its stock. The current price is $7.545, and the recent downgrade of its Medicare star rating from 4 stars to 3.5 stars has resulted in a potential revenue loss of hundreds of millions, which is a critical risk. Additionally, the stock has seen a year-to-date decline of 62.69%, indicating severe market sentiment against it.

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易